Clinical trial
A Multicenter, Randomized, Double-Masked Study To Compare The Ocular Safety, Tolerability, And Efficacy Of A Topical 0.2% Ophthalmic Corticosteroid Solution (SURF-201) To Vehicle In Cataract Surgery Subjects
NCT04324359 is registered in ClinicalTrials.gov with Surface Ophthalmics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double-Masked Study To Compare The Ocular Safety, Tolerability, And Efficacy Of A Topical 0.2% Ophthalmic Corticosteroid Solution (SURF-201) To Vehicle In Cataract Surgery Subjects
- Lead sponsor
- Surface Ophthalmics, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 3, 2020
- Completion date
- November 20, 2020
- Enrollment
- 91 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
post-surgical ocular inflammation, post-surgical ocular pain